Global Recombinant Human Thrombin for Surgical Hemostasis Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Recombinant Human Thrombin for Surgical Hemostasis is a medication or product that contains artificially produced human thrombin, which is used in surgical procedures to promote blood clotting and control bleeding. Thrombin is a protein involved in the blood clotting process, and when applied topically or locally during surgery, it helps to accelerate the formation of blood clots and stop bleeding. This product is commonly used in various surgical specialties, such as cardiovascular surgery, orthopedic surgery, and general surgery, to help achieve hemostasis and prevent excessive bleeding.
The global Recombinant Human Thrombin for Surgical Hemostasis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Recombinant Human Thrombin for Surgical Hemostasis Industry Forecast” looks at past sales and reviews total world Recombinant Human Thrombin for Surgical Hemostasis sales in 2023, providing a comprehensive analysis by region and market sector of projected Recombinant Human Thrombin for Surgical Hemostasis sales for 2024 through 2030. With Recombinant Human Thrombin for Surgical Hemostasis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Thrombin for Surgical Hemostasis industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Human Thrombin for Surgical Hemostasis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Thrombin for Surgical Hemostasis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human Thrombin for Surgical Hemostasis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Thrombin for Surgical Hemostasis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Thrombin for Surgical Hemostasis.
United States market for Recombinant Human Thrombin for Surgical Hemostasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Recombinant Human Thrombin for Surgical Hemostasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Recombinant Human Thrombin for Surgical Hemostasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Recombinant Human Thrombin for Surgical Hemostasis players cover Takeda, Bayer, CSL, Grifols, GE Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Thrombin for Surgical Hemostasis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Recombinant Human Thrombin for Surgical Hemostasis market?
What factors are driving Recombinant Human Thrombin for Surgical Hemostasis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Human Thrombin for Surgical Hemostasis market opportunities vary by end market size?
How does Recombinant Human Thrombin for Surgical Hemostasis break out by Type, by Application?
Recombinant Human Thrombin for Surgical Hemostasis is a medication or product that contains artificially produced human thrombin, which is used in surgical procedures to promote blood clotting and control bleeding. Thrombin is a protein involved in the blood clotting process, and when applied topically or locally during surgery, it helps to accelerate the formation of blood clots and stop bleeding. This product is commonly used in various surgical specialties, such as cardiovascular surgery, orthopedic surgery, and general surgery, to help achieve hemostasis and prevent excessive bleeding.
The global Recombinant Human Thrombin for Surgical Hemostasis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Recombinant Human Thrombin for Surgical Hemostasis Industry Forecast” looks at past sales and reviews total world Recombinant Human Thrombin for Surgical Hemostasis sales in 2023, providing a comprehensive analysis by region and market sector of projected Recombinant Human Thrombin for Surgical Hemostasis sales for 2024 through 2030. With Recombinant Human Thrombin for Surgical Hemostasis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Thrombin for Surgical Hemostasis industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Human Thrombin for Surgical Hemostasis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Thrombin for Surgical Hemostasis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human Thrombin for Surgical Hemostasis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Thrombin for Surgical Hemostasis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Thrombin for Surgical Hemostasis.
United States market for Recombinant Human Thrombin for Surgical Hemostasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Recombinant Human Thrombin for Surgical Hemostasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Recombinant Human Thrombin for Surgical Hemostasis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Recombinant Human Thrombin for Surgical Hemostasis players cover Takeda, Bayer, CSL, Grifols, GE Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Thrombin for Surgical Hemostasis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Based Bovine
- Based Human
- Others
- Hospitals
- Diagnostics & Clinics
- Academic and Research Institute
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- Bayer
- CSL
- Grifols
- GE Healthcare
- Hualan Biological
- Haematologic Technologies
- Pfizer
- Octapharma
- Omrix Biopharmaceuticals
- Shanghai RAAS
What is the 10-year outlook for the global Recombinant Human Thrombin for Surgical Hemostasis market?
What factors are driving Recombinant Human Thrombin for Surgical Hemostasis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Human Thrombin for Surgical Hemostasis market opportunities vary by end market size?
How does Recombinant Human Thrombin for Surgical Hemostasis break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Recombinant Human Thrombin for Surgical Hemostasis by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Recombinant Human Thrombin for Surgical Hemostasis by Country/Region, 2019, 2023 & 2030
2.2 Recombinant Human Thrombin for Surgical Hemostasis Segment by Type
2.2.1 Based Bovine
2.2.2 Based Human
2.2.3 Others
2.3 Recombinant Human Thrombin for Surgical Hemostasis Sales by Type
2.3.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
2.3.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue and Market Share by Type (2019-2024)
2.3.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Type (2019-2024)
2.4 Recombinant Human Thrombin for Surgical Hemostasis Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics & Clinics
2.4.3 Academic and Research Institute
2.5 Recombinant Human Thrombin for Surgical Hemostasis Sales by Application
2.5.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sale Market Share by Application (2019-2024)
2.5.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue and Market Share by Application (2019-2024)
2.5.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Recombinant Human Thrombin for Surgical Hemostasis Breakdown Data by Company
3.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Sales by Company (2019-2024)
3.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Company (2019-2024)
3.2 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue by Company (2019-2024)
3.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Company (2019-2024)
3.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Company (2019-2024)
3.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Company
3.4 Key Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Product Location Distribution
3.4.2 Players Recombinant Human Thrombin for Surgical Hemostasis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Human Thrombin for Surgical Hemostasis Market Size by Geographic Region (2019-2024)
4.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country/Region (2019-2024)
4.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Sales by Country/Region (2019-2024)
4.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue by Country/Region (2019-2024)
4.3 Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Growth
4.4 APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Growth
4.5 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Growth
4.6 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Growth
5 AMERICAS
5.1 Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Country
5.1.1 Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024)
5.1.2 Americas Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024)
5.2 Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024)
5.3 Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Region
6.1.1 APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2019-2024)
6.1.2 APAC Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (2019-2024)
6.2 APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024)
6.3 APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Human Thrombin for Surgical Hemostasis by Country
7.1.1 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024)
7.1.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024)
7.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024)
7.3 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis by Country
8.1.1 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024)
8.1.2 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024)
8.2 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024)
8.3 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Human Thrombin for Surgical Hemostasis
10.3 Manufacturing Process Analysis of Recombinant Human Thrombin for Surgical Hemostasis
10.4 Industry Chain Structure of Recombinant Human Thrombin for Surgical Hemostasis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Human Thrombin for Surgical Hemostasis Distributors
11.3 Recombinant Human Thrombin for Surgical Hemostasis Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS BY GEOGRAPHIC REGION
12.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Region
12.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Forecast by Region (2025-2030)
12.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Recombinant Human Thrombin for Surgical Hemostasis Forecast by Type (2025-2030)
12.7 Global Recombinant Human Thrombin for Surgical Hemostasis Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.1.3 Takeda Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.2.3 Bayer Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.3.3 CSL Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.4.3 Grifols Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 GE Healthcare
13.5.1 GE Healthcare Company Information
13.5.2 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.5.3 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 GE Healthcare Main Business Overview
13.5.5 GE Healthcare Latest Developments
13.6 Hualan Biological
13.6.1 Hualan Biological Company Information
13.6.2 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.6.3 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Hualan Biological Main Business Overview
13.6.5 Hualan Biological Latest Developments
13.7 Haematologic Technologies
13.7.1 Haematologic Technologies Company Information
13.7.2 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.7.3 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Haematologic Technologies Main Business Overview
13.7.5 Haematologic Technologies Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.8.3 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Octapharma
13.9.1 Octapharma Company Information
13.9.2 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.9.3 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Octapharma Main Business Overview
13.9.5 Octapharma Latest Developments
13.10 Omrix Biopharmaceuticals
13.10.1 Omrix Biopharmaceuticals Company Information
13.10.2 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.10.3 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Omrix Biopharmaceuticals Main Business Overview
13.10.5 Omrix Biopharmaceuticals Latest Developments
13.11 Shanghai RAAS
13.11.1 Shanghai RAAS Company Information
13.11.2 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.11.3 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Shanghai RAAS Main Business Overview
13.11.5 Shanghai RAAS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Recombinant Human Thrombin for Surgical Hemostasis by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Recombinant Human Thrombin for Surgical Hemostasis by Country/Region, 2019, 2023 & 2030
2.2 Recombinant Human Thrombin for Surgical Hemostasis Segment by Type
2.2.1 Based Bovine
2.2.2 Based Human
2.2.3 Others
2.3 Recombinant Human Thrombin for Surgical Hemostasis Sales by Type
2.3.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
2.3.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue and Market Share by Type (2019-2024)
2.3.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Type (2019-2024)
2.4 Recombinant Human Thrombin for Surgical Hemostasis Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics & Clinics
2.4.3 Academic and Research Institute
2.5 Recombinant Human Thrombin for Surgical Hemostasis Sales by Application
2.5.1 Global Recombinant Human Thrombin for Surgical Hemostasis Sale Market Share by Application (2019-2024)
2.5.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue and Market Share by Application (2019-2024)
2.5.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Recombinant Human Thrombin for Surgical Hemostasis Breakdown Data by Company
3.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Sales by Company (2019-2024)
3.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Company (2019-2024)
3.2 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue by Company (2019-2024)
3.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Company (2019-2024)
3.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Company (2019-2024)
3.3 Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Company
3.4 Key Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Product Location Distribution
3.4.2 Players Recombinant Human Thrombin for Surgical Hemostasis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Human Thrombin for Surgical Hemostasis Market Size by Geographic Region (2019-2024)
4.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Recombinant Human Thrombin for Surgical Hemostasis Market Size by Country/Region (2019-2024)
4.2.1 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Sales by Country/Region (2019-2024)
4.2.2 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue by Country/Region (2019-2024)
4.3 Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Growth
4.4 APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Growth
4.5 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Growth
4.6 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Growth
5 AMERICAS
5.1 Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Country
5.1.1 Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024)
5.1.2 Americas Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024)
5.2 Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024)
5.3 Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Region
6.1.1 APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2019-2024)
6.1.2 APAC Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (2019-2024)
6.2 APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024)
6.3 APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Human Thrombin for Surgical Hemostasis by Country
7.1.1 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024)
7.1.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024)
7.2 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024)
7.3 Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis by Country
8.1.1 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024)
8.1.2 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024)
8.2 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024)
8.3 Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Human Thrombin for Surgical Hemostasis
10.3 Manufacturing Process Analysis of Recombinant Human Thrombin for Surgical Hemostasis
10.4 Industry Chain Structure of Recombinant Human Thrombin for Surgical Hemostasis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Human Thrombin for Surgical Hemostasis Distributors
11.3 Recombinant Human Thrombin for Surgical Hemostasis Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT HUMAN THROMBIN FOR SURGICAL HEMOSTASIS BY GEOGRAPHIC REGION
12.1 Global Recombinant Human Thrombin for Surgical Hemostasis Market Size Forecast by Region
12.1.1 Global Recombinant Human Thrombin for Surgical Hemostasis Forecast by Region (2025-2030)
12.1.2 Global Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Recombinant Human Thrombin for Surgical Hemostasis Forecast by Type (2025-2030)
12.7 Global Recombinant Human Thrombin for Surgical Hemostasis Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.1.3 Takeda Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.2.3 Bayer Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.3.3 CSL Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.4.3 Grifols Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 GE Healthcare
13.5.1 GE Healthcare Company Information
13.5.2 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.5.3 GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 GE Healthcare Main Business Overview
13.5.5 GE Healthcare Latest Developments
13.6 Hualan Biological
13.6.1 Hualan Biological Company Information
13.6.2 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.6.3 Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Hualan Biological Main Business Overview
13.6.5 Hualan Biological Latest Developments
13.7 Haematologic Technologies
13.7.1 Haematologic Technologies Company Information
13.7.2 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.7.3 Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Haematologic Technologies Main Business Overview
13.7.5 Haematologic Technologies Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.8.3 Pfizer Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Octapharma
13.9.1 Octapharma Company Information
13.9.2 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.9.3 Octapharma Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Octapharma Main Business Overview
13.9.5 Octapharma Latest Developments
13.10 Omrix Biopharmaceuticals
13.10.1 Omrix Biopharmaceuticals Company Information
13.10.2 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.10.3 Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Omrix Biopharmaceuticals Main Business Overview
13.10.5 Omrix Biopharmaceuticals Latest Developments
13.11 Shanghai RAAS
13.11.1 Shanghai RAAS Company Information
13.11.2 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
13.11.3 Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Shanghai RAAS Main Business Overview
13.11.5 Shanghai RAAS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Human Thrombin for Surgical Hemostasis Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Recombinant Human Thrombin for Surgical Hemostasis Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Based Bovine
Table 4. Major Players of Based Human
Table 5. Major Players of Others
Table 6. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024) & (K Units)
Table 7. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
Table 8. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Type (2019-2024) & ($ million)
Table 9. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Type (2019-2024)
Table 10. Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Recombinant Human Thrombin for Surgical Hemostasis Sale by Application (2019-2024) & (K Units)
Table 12. Global Recombinant Human Thrombin for Surgical Hemostasis Sale Market Share by Application (2019-2024)
Table 13. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Application (2019-2024) & ($ million)
Table 14. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Application (2019-2024)
Table 15. Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Company (2019-2024) & (K Units)
Table 17. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Company (2019-2024)
Table 18. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Company (2019-2024)
Table 20. Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Producing Area Distribution and Sales Area
Table 22. Players Recombinant Human Thrombin for Surgical Hemostasis Products Offered
Table 23. Recombinant Human Thrombin for Surgical Hemostasis Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share Geographic Region (2019-2024)
Table 28. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country/Region (2019-2024)
Table 32. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024) & (K Units)
Table 35. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2019-2024)
Table 36. Americas Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024) & (K Units)
Table 38. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024) & (K Units)
Table 39. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2019-2024) & (K Units)
Table 40. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2019-2024)
Table 41. APAC Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024) & (K Units)
Table 43. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024) & (K Units)
Table 44. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024) & (K Units)
Table 45. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024) & (K Units)
Table 47. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024) & (K Units)
Table 51. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Recombinant Human Thrombin for Surgical Hemostasis
Table 53. Key Market Challenges & Risks of Recombinant Human Thrombin for Surgical Hemostasis
Table 54. Key Industry Trends of Recombinant Human Thrombin for Surgical Hemostasis
Table 55. Recombinant Human Thrombin for Surgical Hemostasis Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Recombinant Human Thrombin for Surgical Hemostasis Distributors List
Table 58. Recombinant Human Thrombin for Surgical Hemostasis Customer List
Table 59. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Type (2025-2030) & (K Units)
Table 70. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Takeda Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 74. Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 75. Takeda Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Takeda Main Business
Table 77. Takeda Latest Developments
Table 78. Bayer Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 79. Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 80. Bayer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Bayer Main Business
Table 82. Bayer Latest Developments
Table 83. CSL Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 85. CSL Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. Grifols Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 89. Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 90. Grifols Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Grifols Main Business
Table 92. Grifols Latest Developments
Table 93. GE Healthcare Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 94. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 95. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. GE Healthcare Main Business
Table 97. GE Healthcare Latest Developments
Table 98. Hualan Biological Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 99. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 100. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Hualan Biological Main Business
Table 102. Hualan Biological Latest Developments
Table 103. Haematologic Technologies Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 104. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 105. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Haematologic Technologies Main Business
Table 107. Haematologic Technologies Latest Developments
Table 108. Pfizer Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 110. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Pfizer Main Business
Table 112. Pfizer Latest Developments
Table 113. Octapharma Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 114. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 115. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Octapharma Main Business
Table 117. Octapharma Latest Developments
Table 118. Omrix Biopharmaceuticals Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 119. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 120. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Omrix Biopharmaceuticals Main Business
Table 122. Omrix Biopharmaceuticals Latest Developments
Table 123. Shanghai RAAS Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 124. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 125. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Shanghai RAAS Main Business
Table 127. Shanghai RAAS Latest Developments
Table 1. Recombinant Human Thrombin for Surgical Hemostasis Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Recombinant Human Thrombin for Surgical Hemostasis Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Based Bovine
Table 4. Major Players of Based Human
Table 5. Major Players of Others
Table 6. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024) & (K Units)
Table 7. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
Table 8. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Type (2019-2024) & ($ million)
Table 9. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Type (2019-2024)
Table 10. Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Recombinant Human Thrombin for Surgical Hemostasis Sale by Application (2019-2024) & (K Units)
Table 12. Global Recombinant Human Thrombin for Surgical Hemostasis Sale Market Share by Application (2019-2024)
Table 13. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Application (2019-2024) & ($ million)
Table 14. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Application (2019-2024)
Table 15. Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Company (2019-2024) & (K Units)
Table 17. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Company (2019-2024)
Table 18. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Company (2019-2024)
Table 20. Global Recombinant Human Thrombin for Surgical Hemostasis Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Recombinant Human Thrombin for Surgical Hemostasis Producing Area Distribution and Sales Area
Table 22. Players Recombinant Human Thrombin for Surgical Hemostasis Products Offered
Table 23. Recombinant Human Thrombin for Surgical Hemostasis Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share Geographic Region (2019-2024)
Table 28. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Recombinant Human Thrombin for Surgical Hemostasis Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country/Region (2019-2024)
Table 32. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024) & (K Units)
Table 35. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2019-2024)
Table 36. Americas Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024) & (K Units)
Table 38. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024) & (K Units)
Table 39. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Region (2019-2024) & (K Units)
Table 40. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region (2019-2024)
Table 41. APAC Recombinant Human Thrombin for Surgical Hemostasis Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024) & (K Units)
Table 43. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024) & (K Units)
Table 44. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024) & (K Units)
Table 45. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024) & (K Units)
Table 47. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Type (2019-2024) & (K Units)
Table 51. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Recombinant Human Thrombin for Surgical Hemostasis
Table 53. Key Market Challenges & Risks of Recombinant Human Thrombin for Surgical Hemostasis
Table 54. Key Industry Trends of Recombinant Human Thrombin for Surgical Hemostasis
Table 55. Recombinant Human Thrombin for Surgical Hemostasis Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Recombinant Human Thrombin for Surgical Hemostasis Distributors List
Table 58. Recombinant Human Thrombin for Surgical Hemostasis Customer List
Table 59. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC Recombinant Human Thrombin for Surgical Hemostasis Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Type (2025-2030) & (K Units)
Table 70. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Takeda Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 74. Takeda Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 75. Takeda Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Takeda Main Business
Table 77. Takeda Latest Developments
Table 78. Bayer Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 79. Bayer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 80. Bayer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Bayer Main Business
Table 82. Bayer Latest Developments
Table 83. CSL Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 85. CSL Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. Grifols Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 89. Grifols Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 90. Grifols Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Grifols Main Business
Table 92. Grifols Latest Developments
Table 93. GE Healthcare Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 94. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 95. GE Healthcare Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. GE Healthcare Main Business
Table 97. GE Healthcare Latest Developments
Table 98. Hualan Biological Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 99. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 100. Hualan Biological Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Hualan Biological Main Business
Table 102. Hualan Biological Latest Developments
Table 103. Haematologic Technologies Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 104. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 105. Haematologic Technologies Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Haematologic Technologies Main Business
Table 107. Haematologic Technologies Latest Developments
Table 108. Pfizer Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 110. Pfizer Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Pfizer Main Business
Table 112. Pfizer Latest Developments
Table 113. Octapharma Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 114. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 115. Octapharma Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Octapharma Main Business
Table 117. Octapharma Latest Developments
Table 118. Omrix Biopharmaceuticals Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 119. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 120. Omrix Biopharmaceuticals Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Omrix Biopharmaceuticals Main Business
Table 122. Omrix Biopharmaceuticals Latest Developments
Table 123. Shanghai RAAS Basic Information, Recombinant Human Thrombin for Surgical Hemostasis Manufacturing Base, Sales Area and Its Competitors
Table 124. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Product Portfolios and Specifications
Table 125. Shanghai RAAS Recombinant Human Thrombin for Surgical Hemostasis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Shanghai RAAS Main Business
Table 127. Shanghai RAAS Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant Human Thrombin for Surgical Hemostasis
Figure 2. Recombinant Human Thrombin for Surgical Hemostasis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Recombinant Human Thrombin for Surgical Hemostasis Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country/Region (2023)
Figure 10. Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Based Bovine
Figure 12. Product Picture of Based Human
Figure 13. Product Picture of Others
Figure 14. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type in 2023
Figure 15. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Type (2019-2024)
Figure 16. Recombinant Human Thrombin for Surgical Hemostasis Consumed in Hospitals
Figure 17. Global Recombinant Human Thrombin for Surgical Hemostasis Market: Hospitals (2019-2024) & (K Units)
Figure 18. Recombinant Human Thrombin for Surgical Hemostasis Consumed in Diagnostics & Clinics
Figure 19. Global Recombinant Human Thrombin for Surgical Hemostasis Market: Diagnostics & Clinics (2019-2024) & (K Units)
Figure 20. Recombinant Human Thrombin for Surgical Hemostasis Consumed in Academic and Research Institute
Figure 21. Global Recombinant Human Thrombin for Surgical Hemostasis Market: Academic and Research Institute (2019-2024) & (K Units)
Figure 22. Global Recombinant Human Thrombin for Surgical Hemostasis Sale Market Share by Application (2023)
Figure 23. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Application in 2023
Figure 24. Recombinant Human Thrombin for Surgical Hemostasis Sales by Company in 2023 (K Units)
Figure 25. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Company in 2023
Figure 26. Recombinant Human Thrombin for Surgical Hemostasis Revenue by Company in 2023 ($ millions)
Figure 27. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Company in 2023
Figure 28. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales 2019-2024 (K Units)
Figure 31. Americas Recombinant Human Thrombin for Surgical Hemostasis Revenue 2019-2024 ($ millions)
Figure 32. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales 2019-2024 (K Units)
Figure 33. APAC Recombinant Human Thrombin for Surgical Hemostasis Revenue 2019-2024 ($ millions)
Figure 34. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales 2019-2024 (K Units)
Figure 35. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue 2019-2024 ($ millions)
Figure 38. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country in 2023
Figure 39. Americas Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2019-2024)
Figure 40. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
Figure 41. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2019-2024)
Figure 42. United States Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region in 2023
Figure 47. APAC Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2019-2024)
Figure 48. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
Figure 49. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2019-2024)
Figure 50. China Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 54. India Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 56. China Taiwan Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country in 2023
Figure 58. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2019-2024)
Figure 59. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
Figure 60. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2019-2024)
Figure 61. Germany Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 62. France Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2019-2024)
Figure 69. Egypt Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 72. Turkey Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Recombinant Human Thrombin for Surgical Hemostasis in 2023
Figure 75. Manufacturing Process Analysis of Recombinant Human Thrombin for Surgical Hemostasis
Figure 76. Industry Chain Structure of Recombinant Human Thrombin for Surgical Hemostasis
Figure 77. Channels of Distribution
Figure 78. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Forecast by Region (2025-2030)
Figure 79. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Recombinant Human Thrombin for Surgical Hemostasis
Figure 2. Recombinant Human Thrombin for Surgical Hemostasis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Recombinant Human Thrombin for Surgical Hemostasis Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country/Region (2023)
Figure 10. Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Based Bovine
Figure 12. Product Picture of Based Human
Figure 13. Product Picture of Others
Figure 14. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type in 2023
Figure 15. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Type (2019-2024)
Figure 16. Recombinant Human Thrombin for Surgical Hemostasis Consumed in Hospitals
Figure 17. Global Recombinant Human Thrombin for Surgical Hemostasis Market: Hospitals (2019-2024) & (K Units)
Figure 18. Recombinant Human Thrombin for Surgical Hemostasis Consumed in Diagnostics & Clinics
Figure 19. Global Recombinant Human Thrombin for Surgical Hemostasis Market: Diagnostics & Clinics (2019-2024) & (K Units)
Figure 20. Recombinant Human Thrombin for Surgical Hemostasis Consumed in Academic and Research Institute
Figure 21. Global Recombinant Human Thrombin for Surgical Hemostasis Market: Academic and Research Institute (2019-2024) & (K Units)
Figure 22. Global Recombinant Human Thrombin for Surgical Hemostasis Sale Market Share by Application (2023)
Figure 23. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Application in 2023
Figure 24. Recombinant Human Thrombin for Surgical Hemostasis Sales by Company in 2023 (K Units)
Figure 25. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Company in 2023
Figure 26. Recombinant Human Thrombin for Surgical Hemostasis Revenue by Company in 2023 ($ millions)
Figure 27. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Company in 2023
Figure 28. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales 2019-2024 (K Units)
Figure 31. Americas Recombinant Human Thrombin for Surgical Hemostasis Revenue 2019-2024 ($ millions)
Figure 32. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales 2019-2024 (K Units)
Figure 33. APAC Recombinant Human Thrombin for Surgical Hemostasis Revenue 2019-2024 ($ millions)
Figure 34. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales 2019-2024 (K Units)
Figure 35. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue 2019-2024 ($ millions)
Figure 38. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country in 2023
Figure 39. Americas Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2019-2024)
Figure 40. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
Figure 41. Americas Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2019-2024)
Figure 42. United States Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Region in 2023
Figure 47. APAC Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Region (2019-2024)
Figure 48. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
Figure 49. APAC Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2019-2024)
Figure 50. China Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 54. India Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 56. China Taiwan Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country in 2023
Figure 58. Europe Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share by Country (2019-2024)
Figure 59. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
Figure 60. Europe Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2019-2024)
Figure 61. Germany Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 62. France Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share by Application (2019-2024)
Figure 69. Egypt Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 72. Turkey Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Recombinant Human Thrombin for Surgical Hemostasis Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Recombinant Human Thrombin for Surgical Hemostasis in 2023
Figure 75. Manufacturing Process Analysis of Recombinant Human Thrombin for Surgical Hemostasis
Figure 76. Industry Chain Structure of Recombinant Human Thrombin for Surgical Hemostasis
Figure 77. Channels of Distribution
Figure 78. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Forecast by Region (2025-2030)
Figure 79. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Recombinant Human Thrombin for Surgical Hemostasis Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Recombinant Human Thrombin for Surgical Hemostasis Revenue Market Share Forecast by Application (2025-2030)
